Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
2,396
Views
4
CrossRef citations to date
0
Altmetric
Neurology

Modelling the value of innovative treatments for Alzheimer’s disease in the United States

Charles Makina Medical Health Outcomes Research, Biogen, Cambridge, MA, USACorrespondence[email protected]
,
Peter Neumannb Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
,
Sue Peschinc Alliance for Aging Research, Washington, DC, USA
&
Dana Goldmand Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA, USA
Pages 764-769 | Received 04 Mar 2021, Accepted 05 May 2021, Published online: 04 Jun 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Akina Takami, Masafumi Kato, Hisato Deguchi & Ataru Igarashi. (2023) Value elements and methods of value-based pricing for drugs in Japan: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 23:7, pages 749-759.
Read now

Articles from other publishers (3)

Malaz Boustani, Erin G. Doty, Louis P. GarrisonJrJr, Lee J. Smolen, Mark Belger, Timothy M. Klein, Daniel R. Murphy, Russel Burge, J.K. Wall & Joseph A. Johnston. (2022) Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease. Clinical Therapeutics 44:11, pages 1449-1462.
Crossref
Som Singh, Felix Yang, Andy Sivils, Victoria Cegielski & Xiang-Ping Chu. (2022) Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease. Biomolecules 12:7, pages 996.
Crossref
William L. Herring, Ian Gopal Gould, Howard Fillit, Peter Lindgren, Fiona Forrestal, Robin Thompson & Peter Pemberton-Ross. (2021) Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer’s Disease. Neurology and Therapy 10:2, pages 919-940.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.